Mark Antenucci, D.P.M
Podiatrist in Roswell, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,498 in Podiatrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mark Antenucci, D.P.M reported a CMS MIPS final score of 0/100 - below the 83.1 national average - and filed 150 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 150
- Part D claims, 2023
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Antenucci, D.P.M's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Antenucci, D.P.M sits
This provider among podiatrist peers
Across the 2,987 podiatrist providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Antenucci, D.P.M writes more Part D claims than 37% of them and scores higher on MIPS quality than 0% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one podiatrist peer from a representative sample of 60; the gold marker is Mark Antenucci, D.P.M. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Mark Antenucci, D.P.M?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Mexico
How Podiatrist compares to other specialties among New Mexico providers
Podiatrist ranks #81 among New Mexico's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New Mexico provider total, by primary NUCC taxonomy. The highlighted bar is Podiatrist; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mark Antenucci, D.P.M's 2023 MIPS final score plotted against the Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Podiatrist) - 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Podiatrist US NPIs
0/100 MIPS final score - 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Podiatrist. Quality dim: 0.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Antenucci, D.P.M appears in the CMS NPPES registry as a Podiatrist provider holding D.P.M credentials at 313 WEST COUNTRY CLUB RD., Roswell, NM, 88201, with a listed phone of (575) 624-2398. NPI 1760490759 was issued on 08/04/2006.
Medicare Part D records for calendar year 2023 show 150 prescription claims written by this provider, covering 59 Medicare beneficiaries and totaling roughly $4K in drug spend. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1760490759 |
|---|---|
| Specialty | Podiatrist |
| Credentials | D.P.M |
| Gender | Male |
| NPI Issued | 08/04/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Antenucci, D.P.M's current license status, disciplinary history, and board certifications with the New Mexico Medical Board in New Mexico before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1760490759 is the unique 10-digit identifier CMS uses to link Antenucci across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 191
- Total Day Supply
- 4,378
- Brand Drug Cost
- $0
- Generic Drug Cost
- $4K
- Antibiotic Claims
- 14
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.58
- Gender Split
- 47% female / 53% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Antenucci, D.P.M prescribes most
Top Medicare Part D drugs by claim count, 2023
- Gabapentin
Gabapentin
54 claims
- Gentamicin Sulfate
Gentamicin Sulfate
28 claims
- Ketoconazole 18
Ketoconazole
18 claims
- Cephalexin 11
Cephalexin
11 claims
| Drug | Claims |
|---|---|
| Gabapentin | 54 |
| Gentamicin Sulfate | 28 |
| Ketoconazole | 18 |
| Cephalexin | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Podiatrist Overview
How Mark Antenucci, D.P.M fits within the Podiatrist landscape nationally.
Mark Antenucci, D.P.M's 150 claims are below the specialty average of 304.
Nearby Podiatrist Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Antenucci.
Compare Podiatrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Mexico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Podiatrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Mexico
Frequently Asked Questions
What is Mark Antenucci, D.P.M's specialty? ▼
How much does Mark Antenucci, D.P.M prescribe under Medicare Part D? ▼
What is Mark Antenucci, D.P.M's Medicare quality score? ▼
Where is Mark Antenucci, D.P.M located? ▼
What is Mark Antenucci, D.P.M's NPI number? ▼
How many Podiatrist providers are there in the US? ▼
What drugs does Mark Antenucci, D.P.M prescribe most often? ▼
Does Mark Antenucci, D.P.M accept Medicare? ▼
How can I verify Mark Antenucci, D.P.M's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology